Next Article in Journal
Chronic Pneumonia Due to Klebsiella oxytoca Mimicking Pulmonary Tuberculosis
Previous Article in Journal
Usage and Usability of One Dry Powder Inhaler Compared to Other Inhalers at Therapy Start: An Open, Non-interventional Observational Study in Poland and Germany
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 83
Issue 5
10.5603/PiAP.2015.0060
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Interstitial Lung Disease Associated with Docetaxel in a Patient Treated for Breast Cancer—A Case Report

by
Monika Pankowska-Supryn
1,*,
Monika Załęska
1,
Barbara Roszkowska-Śliż
1 and
Kazimierz Roszkowski-Śliż
2
1
XI Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, ul. Płocka 26, 01-138 Warsaw, Poland
2
III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, ul. Płocka 26, 01-138 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2015, 83(5), 378-382; https://doi.org/10.5603/PiAP.2015.0060
Submission received: 27 April 2015 / Revised: 8 September 2015 / Accepted: 8 September 2015 / Published: 8 September 2015

Abstract

Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.
Keywords: interstitial lung disease; breast cancer; docetaxel interstitial lung disease; breast cancer; docetaxel

Share and Cite

MDPI and ACS Style

Pankowska-Supryn, M.; Załęska, M.; Roszkowska-Śliż, B.; Roszkowski-Śliż, K. Interstitial Lung Disease Associated with Docetaxel in a Patient Treated for Breast Cancer—A Case Report. Adv. Respir. Med. 2015, 83, 378-382. https://doi.org/10.5603/PiAP.2015.0060

AMA Style

Pankowska-Supryn M, Załęska M, Roszkowska-Śliż B, Roszkowski-Śliż K. Interstitial Lung Disease Associated with Docetaxel in a Patient Treated for Breast Cancer—A Case Report. Advances in Respiratory Medicine. 2015; 83(5):378-382. https://doi.org/10.5603/PiAP.2015.0060

Chicago/Turabian Style

Pankowska-Supryn, Monika, Monika Załęska, Barbara Roszkowska-Śliż, and Kazimierz Roszkowski-Śliż. 2015. "Interstitial Lung Disease Associated with Docetaxel in a Patient Treated for Breast Cancer—A Case Report" Advances in Respiratory Medicine 83, no. 5: 378-382. https://doi.org/10.5603/PiAP.2015.0060

Article Metrics

Back to TopTop